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Abstract: The continuing use of transgenic crops has led to an increased interest in the fate of insecticidal crystalline (Cry) proteins in the
environment. Enzyme-linked immunosorbent assays (ELISAs) have emerged as the preferred detection method for Cry proteins in
environmental matrices. Concerns exist that ELISAs are capable of detecting fragments of Cry proteins, which may lead to an
overestimation of the concentration of these proteins in the environment. Five model systems were used to generate fragments of the
Cry1Ab protein, which were then analyzed by ELISAs and bioassays. Fragments from 4 of the model systems were not detectable by
ELISA and did not retain bioactivity. Fragments from the proteinase Kmodel systemwere detectable by ELISA and retained bioactivity.
Inmost cases, ELISAs appear to provide an accurate estimation of the amount of Cry proteins in the environment, as detectable fragments
retained bioactivity and nondetectable fragments did not retain bioactivity. Environ Toxicol Chem 2016;35:3101–3112.# 2016 SETAC
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INTRODUCTION
Transgenicmaize expressing 1ormore insecticidal crystalline
(Cry) proteins formanagement of agricultural pests nowaccounts
for 81% of all maize planted in the United States [1]. The
widespread use of these Cry proteins has raised questions
regarding the fate of the proteins in various environmental
matrices. Numerous researchers have addressed questions of
persistence, movement, and stability by detecting and quantify-
ing the amount ofCryproteins in various environmentalmatrices.
Several methods of detection are available to monitor for Cry
proteins in environmental samples, including western blotting
and bioassays; however, the enzyme-linked immunosorbent
assay (ELISA)has emerged as the preferreddetectionmethod [2].
It is a cost-effective method for researchers in academia and
industry, because the kits typically include all required materials
and little specialized training is needed to analyze a large number
of samples in a short time (4–8 h).
Most commercial ELISAkits are primarily designed and used
for quality assurance/quality control procedures—that is, the
detection of Cry proteins in seed and plant tissues to distinguish
genetically modiﬁed crops from non–geneticallymodiﬁed crops.
Thus, before these ELISA kits can be adapted for use with
environmental matrices, the analytical method, including
extraction protocol, must be validated. The steps necessary for
validation of ELISAs for use with environmental samples have
been extensively studied and summarized [3–5]. The main steps
brieﬂy summarized, are: 1) sensitivity—determining the quanti-
tative range and limit of detection and deﬁning the upper and
lower limits of quantitation; 2) speciﬁcity—determining that
there is no cross-reactivity or interferencewith similar proteins or
matrix components to ensure that only the protein of interest is
detected; 3) accuracy—conﬁrming that the amount of protein
detected in the ELISA is close to the actual amount in an
environmental sample; and 4) precision—minimizing variability
to verify that the ELISA results are repeatable across days,
analysts, and laboratories.
Biological validation of ELISAs to ensure that the proteins
detected in environmental samples retain bioactivity is an area of
validation that is understudied. A lack of biological validation is a
major omission because most of the commercially available
ELISA kits utilize polyclonal antibodies. Although use of
polyclonal antibodies leads to very sensitive assays because they
bind tomultiple epitopes on a protein and increase the chances of
detection, their use also increases the likelihood of detecting a
partially degraded protein, producing a false-positive result.
Thus, even though some antibody-binding sites on a partially
degraded protein may be lost, other epitopes on the protein
fragment may be intact and capable of binding with the
antibodies. The binding of antibodies to protein fragments could
result in an ELISA indicating a positive detection in a sample
where no fully intact protein exists. The risk assessments for these
proteins and their associated products are impacted if the false
positive results lead to overestimations of the concentrations of
these proteins in the environment. For example, if ELISA results
indicate that the protein concentrations in the environment
exceed the concentrations needed to cause adverse effects, then
additional restrictionsmay be placed on the use of these products.
Alternatively, if risk assessors use ELISA results that overesti-
mate the concentrations of intact Cry proteins in exposure
assessments, then risk assessments are conservatively protective.
There is a basis for the concern that Cry protein fragments
could produce false-positive results. Einspanier et al. [6] tracked
Cry1Ab with a commercially available ELISA kit as the protein
passed through the gastrointestinal tract of cattle fed transgenic
maize. Their results indicated that the protein accumulated
within the gastrointestinal tract; this effect was not observed in
cattle fed isoline, nontransgenic maize, so the authors ruled out
cross-reactivity with other proteins as the cause of the reported
protein accumulation [6]. A follow-up study tested the
hypothesis that the protein was fragmented, yet still immunore-
active, leading to detection of the fragments with ELISA [7].
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The authors fed transgenic maize containing Cry1Ab to cattle
and collected samples from the gastrointestinal tract at
slaughter. The samples were then analyzed with ELISAs and
western blotting. The ELISA results indicated that the Cry1Ab
protein accumulated in the gastrointestinal tract, as reported in
the ﬁrst study. However, western blotting only detected bands at
approximately 17 kDa and 34 kDa; no fully intact Cry1Ab was
detected, which contradicts the ELISA results [7]. Based on
these results, understanding how fragmented proteins affect
ELISAs and determining if any bioactivity is retained by these
fragments is highly important.
Five optimized model systems were used to generate
Cry1Ab fragments in the present study: chymotrypsin model
system, proteinase Kmodel system, acidic buffer model system,
photodegradation model system, and long-term degradation in
buffer model system [8]. The solutions of fragments generated
by these model systems were analyzed with ELISAs to
determine if the fragments were still detectable and with
bioassays to determine if the fragments retained bioactivity.
MATERIALS AND METHODS
Gel electrophoresis
Fragmentation of the Cry1Ab protein was conﬁrmed for
each model system by polyacrylamide gel electrophoresis
with sodium dodecyl sulfate (SDS-PAGE). Tris (hydrox-
ymethyl)aminomethane hydrochloride (Tris-HCl) gels (15%
acrylamide) used for resolution of larger fragments and parent
protein (10–70 kDa) were purchased from Bio-Rad Labora-
tories (catalog no. 161-1157) or prepared fresh daily
according to a described method [9]. The recipes from
Rosenberg [9] were modiﬁed to ﬁt a Bio-Rad Mini-Protean II
gel apparatus (gel size 83mm 73mm 1mm; Table 1). An
appropriate amount of 4 sample buffer was added to each
sample to obtain a 1 sample buffer concentration. Sample
buffer consisted of 4 g sucrose, 0.8 g SDS, 2.5mL 1M Tris-
HCl (pH 6.8), and 250mL 0.1% (w/v) bromophenol blue
dissolved to 10mL with nanopure water. Samples were boiled
at 100 8C for 3min to 4min, chilled in ice for 10min, and
centrifuged at 12 000 g for 5min. Running buffer (3.03 g Tris,
14.42 g glycine, 1 g SDS, diluted to 1 L with nanopure water)
was added to the upper and lower chambers of the apparatus.
One well on each gel was loaded with 5mL of PageRulerTM
Unstained Broad Range Protein Ladder (Fisher Scientiﬁc)
with molecular bands ranging from 5 kDa to 250 kDa, and
20mL of sample was added to the remaining wells. A
constant 180 volts was applied to the gels until the dye front
was within 1 cm of the bottom of the gel (approximate run
times were 1 h). Gels were stained with either Coomassie
brilliant blue or silver stain and digitized using a Lexmark
X83 All-in-One printer/copier/scanner and Lexmark Viewing
Booth software (Lexmark International). Adobe Photoshop
CS5 (version 12.1 64; Adobe Systems) was used to edit and
annotate each gel.
Coomassie staining
The Coomassie staining procedure was adapted from
Rosenberg [9]. Brieﬂy, 1 g Coomassie brilliant blue R-250
(Fisher Scientiﬁc) was dissolved in 100mL acetic acid and
400mL methanol and diluted to 1 L with nanopure water.
Destain solution was prepared by diluting 100mL acetic acid
and 400mL methanol to 1 L with nanopure water. Staining
occurred for 30min andwas followed by destaining for 2 h to 3 h
or overnight with the destain solution changed 1 or 2 times. All
staining occurred on an orbital shaker (ELMI) at 100 rpm.
Silver staining
The silver staining procedure adapted from Rosenberg [9]
was used. Gels were stored at 4 8C in gel ﬁx solution (50%
[v/v] methanol, 12% [v/v] acetic acid, 38% [v/v] water)
overnight following gel electrophoresis. Each gel was washed
3 times with 50% (v/v) ethanol for 20min each. Each gel was
submerged in sodium thiosulfate (0.2 g/L sodium thiosulfate)
for 1min and immediately rinsed with nanopure water 3 times
for 20 s each. Gels were submerged in silver nitrate solution
(2 g/L silver nitrate, 0.75mL/L 37% [v/v] formaldehyde stock
solution) for 20min and immediately rinsed with nanopure
water 2 times for 20 s each. Developing solution (60 g/L
sodium carbonate, 0.5mL/L 37% [v/v] formaldehyde stock
solution, 4mg/L sodium thiosulfate) was used to visualize
protein bands by submerging the gels for up to 10min. Gels
were washed with nanopure water twice for 2min each to
terminate the developing process. Finally, gels were sub-
merged in gel ﬁx solution for 10min and then in 50% (v/v)
methanol for 20min. All staining occurred at room tempera-
ture on an orbital shaker.
ELISAs
The ELISA kits speciﬁc for Cry1Ab/1Ac (catalog no. PSP
06200) were purchased from Agdia. Samples were analyzed
according to the manufacturer’s instructions. Quantitative
results were obtained through the use of a standard curve. A
Cry1Ab reference standard, provided byMonsanto, was used to
prepare a fresh 1 ng/mL to 20 ng/mL standard curve in the assay
buffer, phosphate-buffered saline (PBS) with Tween 20, daily.
Experiments to validate the speciﬁcity and precision of the assay
for each model system were carried out to ensure the
performance of the assay. Validation of the sensitivity and
accuracy of the assay was not performed; model system samples
were analyzed directly, eliminating the need for fortiﬁcation and
recovery or extraction efﬁciency studies, and all model system
samples were diluted to fall in the middle of the quantitative
range, thus eliminating the possibility of samples falling below
the limit of detection and the lower limit of quantitation.
Speciﬁcity, cross-reactivity, or interference of the model
system components (buffers, enzymes, inhibitors) with the
antibodies in the ELISA kit was determined through buffer
matrix testing. Multiple dilutions (1:5000, 1:10 000, etc.) of
only the model system components were prepared using the
assay buffer. A 2 standard curve (2–40 ng/mL) was prepared
and mixed with equal volumes of the model system dilutions,
resulting in a 1 standard curve in the model system buffer. The
1 standard curves in model system buffer were then analyzed
with ELISAs in conjunction with a 1 standard curve in assay
Table 1. Recipes for separating and stacking gel used in gel electrophoresis
Separating gel Stacking gel
2.474mL 30% acrylamide 0.330mL 30% acrylamide
1.847mL 1M Tris-HCl, pH 8.8 0.247mL 1M Tris-HCl, pH 6.8
0.610mL nanopure water 1.391mL nanopure water
50mL 10% (w/v) sodium
dodecyl sulfate
20mL 10% (w/v) sodium
dodecyl sulfate
4mLN,N,N0,N0-
tetramethylethylenediamine
2mLN,N,N0,N0-
tetramethylethylenediamine
17mL 10% (w/v) ammonium
persulfate
10mL 10% (w/v) ammonium
persulfate
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buffer. The relative percent difference (R%D) was calculated
from each point on the standard curve with the following
equation
R%D ¼ ðmodel system buffer result assay buffer resultÞ
assay buffer result
 100%
Theacceptance criterion for buffermatrix testing is relative percent
difference│15%│ between the assay buffer and model system
buffer [5]. If the relative percent differencewas>│15%│ across 2
consecutive points in the standard curve, then there may be matrix
effects from the model system components.
Precision of the ELISA was validated through the use of
positive and negative controls, standard curve precision, and
dilution agreement. Positive controls (included with the kit) and
negative PBS with Tween 20 controls were included on every
plate. Plates that had standard curve R2< 0.90 were reanalyzed.
Dilution agreement was used to ensure that diluting the model
system samples did not affect quantitation of the protein.
Standardized protein was diluted in the model system
components (buffers, enzymes, inhibitors), and dilutions were
selected to fall above, below, and within the quantitative range.
Dilutions were analyzed with ELISAs, and percent coefﬁcient
of variation (%CV) was calculated across all in-range dilutions
with the following equation
%CV ¼ standard deviation
mean adjusted result
 100%
The acceptance criterion for dilution agreement is a %CV 20%.
If the %CV was >20%, minimum or maximum dilutions were
applied until the %CV was 20%.
Bioassays
Diet for the bioassays was prepared by mixing 3 parts liquid
containing treatment or control solution with 1 part Stoneﬂy
Heliothis diet (Ward’s Science). In addition to the controls
outlined for each model system, a water control and a Cry1Ab
control were prepared fresh at the start of each bioassay. All
samples and controls were diluted so that if all protein was fully
intact, the ﬁnal concentration of protein in the diet would be
94.5 ng/g. This value falls between the 90% and 95% lethal
concentration values for the protein and insect population used in
the study. The use of a high initial concentration allows for easier
observation of any changes in mortality and sublethal effects.
Diet was mixed thoroughly, and 0.3mL of diet was placed into
eachwell. Therewere3 replicates per treatment and16 insects per
replicate (n¼ 48). A single European corn borer neonate,
Ostrinia nubilalis, was placed in each well, and the trays were
incubated at 27 8C (2 8C) and 60% to 70% humidity. European
corn borers were utilized in this experiment because they are
sensitive to Cry1Ab. The Corn Insects and Crop Genetics
Research Unit of the US Department of Agriculture’s Agricul-
tural Research Service kindly provided all European corn borers.
Larvae were assessed for survival and weight gain after 7 d.
Bioassays with <80% survival in the water controls were not
used. Treatment replicates were combined, and an analysis of
variance in SAS 9.3 software (SAS Institute) was used to
determine statistical signiﬁcance (p< 0.05).
Chymotrypsin
Trypsin-activated Cry1Ab protein (salt-free, 96% pure)
dissolved in 50mM N-cyclohexyl-3-aminopropanesulfonic
acid, pH 10.5, was purchased from Case Western Reserve
University; the concentration of the protein in solution was
900mg/mL. Alpha-chymotrypsin from bovine pancreas (cata-
log no. C4129) was purchased from Sigma-Aldrich. Chymo-
trypsin is a serine protease that can act as a surrogate for other
serine proteases. Chymotrypsin also is found in the gastrointes-
tinal tract of vertebrate and invertebrate organisms. Vertebrates,
such as cattle fed on transgenic maize, and invertebrates, such as
detritivores feeding on maize detritus, may excrete Cry protein
fragments into soil and water, where they may be detected by
ELISAs. Additionally, chymotrypsin acts as a surrogate for
other serine proteases, which are ubiquitous in eukaryotes and
prokaryotes. The chymotrypsin model system consisted of a
Cry1Ab control, a chymotrypsin control, and 3 sample
replicates (Table 2). A 5:1mol:mol ratio of enzyme to toxin
was prepared by dissolving chymotrypsin in 100mM potassium
phosphate (KH2PO4) buffer, pH 7. All samples were incubated
at 37 8C for 1 h or 24 h. At termination, 150mL of nanopure
water was added to each sample. Three 50-mL aliquots were
removed for use in gel electrophoresis, ELISA, and bioassays.
All vials were ﬂash-frozen in liquid nitrogen and stored at
–80 8C until analysis.
Table 2. Layout for chymotryspin and proteinase K model systemsa
Samples Initiation Termination
Chymotrypsin
Cry1Ab control 75mL KH2PO4 150mL water
75mL Cry1Ab solution
Chymotrypsin control 75mL KH2PO4 150mL water
75mL chymotrypsin solution in KH2PO4
Treatment 75mL Cry1Ab solution 150mL water
75mL chymotrypsin solution in KH2PO4
Proteinase K
Cry1Ab control 75mL Tris-HCl 150mL water
75mL Cry1Ab solution
Proteinase K control 75mL CAPS 150mL water
75mL proteinase K solution in Tris-HCl
Treatment 75mL Cry1Ab solution 150mL water
75mL proteinase K solution in Tris-HCl
aAt the start of the experiment, the solutions in the initiation column were combined in a vial. All samples were held at 37 8C for 30min (proteinaseK) or 1 h or
24 h (chymotrypsin). At the end of the experiment, the solution in the termination column was added. All samples were ﬂash-frozen in liquid nitrogen and stored
at –80 8C until analysis.
CAPS¼N-cyclohexyl-3-aminopropanesulfonic acid; Tris-HCl¼ tris(hydroxymethyl)aminomethane hydrochloride.
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Long-term degradation in buffer
A model system was set up to explore the degradation of
Cry1Ab protein over time with no environmental inputs. The
long-term degradation in the buffer model system consisted of
3 sample replicates. We placed 100mL of Cry1Ab solution
and 100mL of 50mM N-cyclohexyl-3-aminopropanesulfonic
acid in 1.5-mL vials, which were stored in the dark at room
temperature for 16wk. To maintain consistency with the other
model systems, 200mL of nanopure water was added to each
tube at termination. Three 50-mL aliquots were removed for
use in gel electrophoresis, ELISA, and bioassays. All vials
were ﬂash-frozen in liquid nitrogen and stored at –80 8C until
analysis.
Photodegradation
The photodegradationmodel systemconsisted of 2 treatments
and 3 sample replicates per treatment. Each sample consisting
of 115mL of Cry1Ab solution was placed in a quartz nuclear
magnetic resonance tube. Samples were then placed in a
Rayonet
1
photoreactor (Southern New England Ultraviolet)
and irradiated with 254nm light for either 2.5min or 5min.
Preliminary experiments showed that environmentally relevant
wavelengths did not degrade Cry1Ab, and thus, harsher
ultraviolet (UV) light was used. Following irradiation, 75mL
of sample was transferred into a separate vial, and 225mL of
water was added. Three 50-mL aliquots were removed for use in
gel electrophoresis, ELISA, and bioassays, and all vials were
ﬂash-frozen in liquid nitrogen and stored at –80 8C until analysis.
Acidic buffer
Preliminary testing showed that an acidic buffer could
potentially degrade Cry1Ab. Although the preliminary results
suggested that this model system was useful in generating
numerous fragments of various sizes, these fragments are
probably less environmentally relevant than fragments gener-
ated by other model systems because the acidic conditions under
which the protein fragmented are not widely found in
agricultural settings. The acidic buffer treatment (pH 1.64)
consisted of 4 time points, with 3 samples at each time point. All
samples consisted of 75mL Cry1Ab solution (in N-cyclohexyl-
3-aminopropanesulfonic acid, pH 10.5) and 75mLKH2PO4 (pH
1.3). At each time point, 1 sample was held at room temperature,
while the remaining 2 samples were held at 40 8C. All samples
were terminated with 150mL nanopure water at 4 d, 5 d, 6 d,
or 7 d. After termination, samples were ﬂash-frozen with
liquid nitrogen and stored at –80 8C until analysis with gel
electrophoresis.
Proteinase K
Proteinase K is the main proteolytic enzyme found in
Engyodontium album (formerly Tritirachium album), a fungus
that has been found in the cysts of soybean plants and found to
be associated with reeds in wetland areas. Proteinase K from
E. albumwas purchased from Sigma-Aldrich, and a 1:1mol:mol
ratio of enzyme to toxin was prepared by dissolving proteinase
K in 20mM Tris-HCl buffer, pH 7.5. The proteinase K model
system consisted of a Cry1Ab control, a proteinase K control,
and 3 sample replicates (Table 2). All samples were incubated at
37 8C for 30min. At termination, 150mL of nanopure water was
added to each sample, and then 3 50-mL aliquots were removed
for use in gel electrophoresis, ELISAs, and bioassays. All vials
were ﬂash-frozen in liquid nitrogen and stored at –80 8C until
analysis.
Following analysis of the proteinase K treatments, a mass
digest of Cry1Ab was set up to generate sufﬁcient quantities
of fragments for additional analysis. For this mass digest,
4.5mL of Cry1Ab solution was incubated with 4.5mL of
proteinase K at 37 8C for 30min. At termination, 9mL of
nanopure water was added; aliquots of 50mL, 300mL, and
1mL were prepared; and all aliquots were ﬂash-frozen in
liquid nitrogen and stored at –80 8C. A Cry1Ab control
(4.5mL Cry1Ab and 4.5mL 20mM Tris-HCl; terminated
with 9mL water) and a proteinase K control (4.5mL 50mM
N-cyclohexyl-3-aminopropanesulfonic acid and 4.5mL pro-
teinase K solution; terminated with 9mL water) also were
prepared and subjected to the same conditions. Gel electro-
phoresis was performed on an aliquot of the mass digest to
conﬁrm that the degradation pattern remained the same.
An aliquot of the mass digest was subjected to gel
electrophoresis with a tris-tricine gel; the use of a tris-tricine
gel allowed for resolution of fragments with low molecular
weights. The tris-tricine gels (16.5% acrylamide, catalog no.
456-3064), running buffer (catalog no. 161-0744), sample
buffer (catalog no. 161-0739), and polypeptide SDS-PAGE
standards (catalog no. 161-0326) were purchased from Bio-
Rad Laboratories and prepared according to the manufac-
turer’s directions. Equal volumes of sample and sample buffer
were combined and heated at 95 8C for 5min, chilled in ice
for 10min, and centrifuged at 12 000 g for 5min. Then, 20mL
of sample was loaded into the lanes, and a constant 100 volts
was applied to the gel until the dye front was within 1 cm of
the bottom of the gel (approximate run time was 2 h). The gel
was stained with silver stain and digitized as previously
described.
A separatory column was used to isolate fragments for
further analysis. Sephadex
1
G-50 separatory medium was
purchased from Sigma-Aldrich and placed in excess 50mM
sodium phosphate buffer (with 15mM NaCl, pH 7.0)
overnight to allow the beads to swell. Suspended particles
were decanted, and the medium was degassed for 15min with
occasional swirling. Glass wool was placed in the bottom of a
1-cm-diameter column, and 0.5 cm of sand was added to
prevent column blockage. The column was ﬁlled one-third full
with fresh buffer, and the gel was poured in 1 continuous step
until the desired height of 12.7 cm was reached (10mL
approximate column volume). The gel was allowed to settle
for 10min, and then the outlet was opened to achieve even
sedimentation; fresh buffer was continuously added to ensure
that the column did not run dry. Following sedimentation,
the outlet was closed and excess buffer was removed with a
Pasteur pipet. A 3-mL volume of sample was added via
Pasteur pipet, and the outlet was opened to allow the sample to
enter the column bed, at which time the outlet was closed.
Additional sample buffer was carefully added with a Pasteur
pipet, the outlet was opened, and fraction collection was
initiated. Fifteen 1-mL fractions were collected from the 3
mass digest samples. A Nano-Drop
1
ND-1000 spectropho-
tometer was used to determine the protein concentration in
each fraction by recording absorbance at 280 nm.
Following separation of the fragments, ELISAs were
performed on selected fractions for all 3 samples. The total
amount of protein in the fractions varied from fraction to
fraction. To account for this variation, the protein concentration
determined by Nano-Drop spectrophotometry (Table 3) was
used as a starting point, and all fractions were appropriately
diluted so that the ﬁnal concentration of total protein in each
fraction was 11.25 ng/mL for the ELISA.
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RESULTS
Chymotrypsin
The chymotrypsin model system produced minor degrada-
tion of Cry1Ab at 1 h (Figure 1A). Signiﬁcantly more
degradation of the protein was observed at 24 h (Figure 1B);
chymotrypsin was almost completely degraded at 24 h, so
longer incubations were not investigated. There was no
difference in the number of fragments produced by the different
incubations times; both yielded 2 fragments, approximately
25 kDa and 34 kDa in size.
Buffer matrix and dilution agreement (%CV¼ 8.00) testing
indicated that there would be no effects on the ELISA results if a
dilution factor of 1:22 500 was applied to the samples. At 1 h,
ELISA results indicated that very little degradation of the
protein occurred; 95% to 110% of the parent protein remained
(Table 4). After 24 h, ELISA results indicated that the Cry1Ab
protein had been signiﬁcantly degraded, with only 21% to
68% of the parent protein remaining. Average survival for
insects in the 1-h treatments was 34.7% and 77.6% for the 24-h
treatments (Figure 2). The average weight of the insects was
higher in the 24-h treatment (0.90mg) compared to the 1-h
treatment (0.34mg; F¼ 67.64, degrees of freedom [df] 7, 299,
p< 0.0001).
Long-term degradation in buffer
The long-term degradation (16wk) of Cry1Ab in only
N-cyclohexyl-3-aminopropanesulfonic acid buffer produced
multiple protein fragments (Figure 1C). The majority of the
fragments produced were 3 fragments of approximately 27 kDa,
40 kDa, and 45 kDa; several fragments of 25 kDa or smaller
were also visualized. Buffer matrix and dilution agreement
(%CV¼ 4.85) testing determined that there would be no
signiﬁcant effects on the ELISA results if samples were diluted
by a factor of 1:22 500. Since both the long-term degradation
model system and the photodegradationmodel system consisted
of only N-cyclohexyl-3-aminopropanesulfonic acid and water,
the results from the buffer matrix and dilution agreement tests
also were used to determine the dilutions used in the
photodegradation model system.
The ELISA results indicated that signiﬁcant degradation of
the protein occurred; approximately 50% of the fully intact
protein remained (Table 4). The average larval survival for the
treatments (70.1%) was slightly lower than the water control
survival (F¼ 22.37, df 2, 237, p¼ 0.0044); however, average
larval weight was greatly reduced compared with the water
control, 0.75mg and 6.60mg, respectively (Figure 3A;
F¼ 96.88, df 2, 147, p< 0.0001).
Photodegradation
Signiﬁcant degradation of Cry1Ab occurred at both time
points, but fully intact protein remained (Figure 1D). A greater
number of fragments and higher quantities of all fragments were
present in the 5-min samples than the 2.5-min samples.
Signiﬁcant smearing was observed in the gel in all samples.
The smearing was contained above 100 kDa, and thus it did not
interfere with fragment visualization. All samples were diluted
by a factor of 1:22 500 prior to ELISA, as determined previously
(see Long-term degradation in buffer section). The Cry1Ab
protein was detected at a low level by ELISA in only 1 of 3 2.5-
min samples and was not detected in any of the 5-min samples
(Table 4), despite the presence of small amounts of Cry1Ab in
all samples, as indicated by the gel (Figure 1D). There were no
signiﬁcant differences between the 2.5-min and 5-min samples
and the water control for larval survival; survival in all 3 was
greater than 97% (Figure 3B; F¼ 24.77, df 3, 392, p¼ 0.8929
and 0.9411, respectively, for 2.5min and 5min). Fragments of
the photodegradation model system did not appear to have
sublethal effects, as no signiﬁcant differences were present
between the water control and the 2.5-min samples. Average
weight in the 5-min treatments was signiﬁcantly higher than the
water control, suggesting a possible increase in growth; but this
was not investigated further (F¼ 153.79, df 3, 347, p< 0.0001).
Acidic buffer
Minimal degradation was observed in the 4 room tempera-
ture controls. Signiﬁcant degradation of the protein was
observed in the 40 8C treatments at all 4 time points, with
nearly all the parent protein completely degraded after 7 d
(Figure 4). There were larger numbers of different protein
fragments in the treatments, but the quantities of each fragment
were low; the prominent band for most samples was near 5 kDa.
Buffer matrix and dilution agreement (%CV¼ 19.11) testing
indicated that there would be no signiﬁcant effects on the ELISA
results if samples were diluted by a factor of 1:22 500. No
Cry1Ab was detected in any of the room temperature controls or
the 40 8C treatments by ELISA (Table 5). Bioassays of the 4-d
and 5-d samples and the 6-d and 7-d samples were performed on
different days. Larval survival in all model system controls and
treatments was high (>80%), and there were no signiﬁcant
differences when compared to the water control (Figure 3C and
D; 4-d and 5-d samples, F¼ 13.35, df 5, 375, p¼ 0.9703 and
0.8244, respectively; 6-d and 7-d samples, F¼ 8.99, df 5, 392,
p¼ 0.6414 and 0.7399, respectively). Average weight of the
insects in the 4-d room temperature control was low, suggesting
possible sublethal effects; but this difference was not statisti-
cally signiﬁcant. Average weight of the insects in the 6-d and
7-d 40 8C treatment was signiﬁcantly lower than the water
Table 3. Enzyme-linked immunosorbent assay results of the fractions from
the G-50 separatory column experimenta
Fraction Absorbance
Concentration
(ng/mL)
Adjusted concentration
(ng/mL)
Treatment
4 0.299 1.59 11 284
5 0.330 2.00 24 863
6 0.493 4.19 33 654
7 0.232 0.68 4245
12 0.000 0.00 0
13 0.006 0.00 0
Proteinase K
4 0.008 0.00 0
5 0.004 0.00 0
6 0.004 0.00 0
7 0.005 0.00 0
12 0.005 0.00 0
13 0.019 0.00 0
Cry1Ab
4 0.007 0.00 0
5 0.354 2.33 51 792
6 0.840 8.87 118 051
7 0.917 9.92 35 265
12 0.050 0.00 0
13 0.028 0.00 0
aTreatment was Cry1Ab degraded with proteinase K; proteinase K and
Cry1Ab were used alone. Adjusted concentration was calculated by
correcting for the amount of total protein present in each fraction.
Signiﬁcant amounts of protein were still detectable in the treatments that
have been degraded by proteinase K.
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Figure 1. Degradation of Cry1Ab with the 3 model systems. (A) 1-h and (B) 24-h chymotrypsin model system; degradation occurred at both time points, with
only 2 Cry1Ab fragment bands visualized. (C) Long-term degradation in buffer model system after a 16-wk incubation; degradation occurred, but signiﬁcant
parent protein remains. (D) Photodegradation model system; samples were exposed to 254 nm light for 2.5min or 5min; degradation occurred, but
polymerization of full protein and/or fragments also occurred. Chymo. control¼ chymotrypsin in buffer only; Cry1Ab¼ freshly prepared protein; Cry1Ab
control¼Cry1Ab only; Rep 1 through 3¼ treatments containing Cry1Ab and chymotrypsin (A,B) or treatments containing Cry1Ab in 50mMN-cyclohexyl-3-
aminopropanesulfonic acid buffer (C, D).
Table 4. Enzyme-linked immunosorbent assay results from the chymotrypsin, long-term degradation in buffer, and photodegradation model systemsa
Absorbance Concentration (ng/mL) Adjusted concentration (ng/mL) % Cry1Ab remaining
Chymotrypsin 1-h digestionb
Cry1Ab control 0.466 4.22 95 000
Chymotrypsin control 0.034 2.83 0
Replicate 1 0.493 4.66 104 804 110.3%
Replicate 2 0.456 4.06 91 324 96.13
Replicate 3 0.456 4.05 91 160 95.96
Chymotrypsin 24-h digestionb
Cry1Ab control 0.338 2.14 48 105
Chymotrypsin control 0.008 3.27 0
Replicate 1 0.258 0.83 18 652 38.77
Replicate 2 0.296 1.45 32 663 67.90
Replicate 3 0.235 0.45 10 155 21.11
Long-term degradation in bufferc
Cry1Ab control 0.553 5.75 129 333
Buffer control 0.002 2.12 0
Replicate 1 0.354 2.90 65 317 50.50
Replicate 2 0.362 3.01 67 743 52.38
Replicate 3 0.349 2.83 63 570 49.15
Photodegradation at 254 nmd
Cry1Ab control 0.636 6.04 136 003
Buffer control 0.002 1.78 0
2.5min
Replicate 1 0.144 0.00 0 0.00
Replicate 2 0.156 0.15 3457 2.54
Replicate 3 0.033 1.35 0 0.00
5min
Replicate 1 0.062 1.01 0 0.00
Replicate 2 0.027 1.43 0 0.00
Replicate 3 0.134 0.11 0 0.00
a
“Adjusted concentration”was calculated bymultiplying by the dilution factor, 1:22 500. “%Cry1Ab remaining”was calculated by dividing the concentration of
each of the replicates by the Cry1Ab control concentration.
bChymotrypsin: Results indicate little degradation at 1 h and signiﬁcant degradation at 24 h.
cLong-term degradation in buffer: Results indicate signiﬁcant degradation after 16wk.
dPhotodegradation: Results indicate signiﬁcant degradation at 2.5min and 5min.
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control, suggesting possible sublethal effects (F¼ 28.55, df 5,
349, p< 0.0001 for both the 6-d and 7-d treatments). All other
treatments and controls were either not signiﬁcantly different
from the water control or statistically higher than the water
control.
Proteinase K
The proteinase K model system completely degraded the
Cry1Ab protein (Figure 5A). The resulting degradation pattern
was dominated by a fragment ormultiple fragments in the 5-kDa
range. Smaller quantities of additional fragments in the 10-kDa
Figure 2. (A) Survival of insects fed a diet prepared from the chymotrypsin model system. (B) Average weight of insects fed a diet prepared from the
chymotrypsin model system. Determination of signiﬁcance required the data to be log-transformed because of a low number of individuals in some of the
treatments. Letters indicate signiﬁcance across treatments (p¼ 0.05). Chymo¼ chymotrypsin in buffer only; Cry1Ab¼Cry1Ab only; Treatment¼ treatments
containing Cry1Ab and chymotrypsin.
Figure 3. Survival and average weight of surviving insects fed fragments from the tested model systems. Uppercase letters indicate signiﬁcance within survival
across treatments (p¼ 0.05). Lowercase letters indicate signiﬁcance within average weight across treatments (p¼ 0.05). Each bioassay has a water control and a
Cry1Ab control. (A) Long-term degradation in buffermodel system; treatment was Cry1Ab degraded over 16wk at room temperature in 50mMN-cyclohexyl-3-
aminopropanesulfonic acid buffer, pH 10.5; (B) Photodegradation model system; (C) 4-d to 5-d acidic buffer model system; (D) 6-d to 7-d acidic buffer model
system; (E, F) ﬁrst and second runs of the proteinase K model system. 4D RT/5D RT/6D RT/7D RT¼Cry1Ab incubated in acidic buffer (pH 1.64) at room
temperature for 4/5 d; 4D Treat/5D Treat/6D Treat/7D Treat¼Cry1Ab incubated in acidic buffer (pH 1.64) at 40 8C for 4/5/6/7 d; MSCry1Ab¼Cry1Ab
subjected to the model system treatment (37 8C for 30min); Prtn. K¼ proteinase K in buffer only; Treatment¼ treatment containing Cry1Ab and proteinase K;
2.5min¼ 2.5-min exposure to 254 nm light; 5min¼ 5-min exposure to 254 nm light.
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to 15-kDa range were also present. Buffer matrix and dilution
agreement (%CV¼ 11.11) testing indicated that ELISA results
would not be affected if a dilution factor of 1:20 000 was applied
to all samples prior to analysis. The ELISA results of the
proteinase K treatments indicated that the Cry1Ab fragments
were still highly detectable by the ELISA antibodies (Table 5).
Signiﬁcant biological effects were observed in all treatments.
These bioassays were performed a second time, and the
combined data are presented (Figure 3E; n¼ 96). Survival in the
treatments (52.4%) was comparable to the Cry1Ab controls
(47–60%) and signiﬁcantly lower than the water and proteinase
K controls (95% and 92%, respectively). Average weight of the
insects fed the diet containing the treatment solutions (0.33mg)
did not differ from the Cry1Ab controls (0.32–0.54mg) but was
signiﬁcantly lower than the water and proteinase K controls
(6.61mg and 6.35mg, respectively).
In light of the results shown by gel electrophoresis (protein is
highly degraded) and ELISAs and bioassays (protein still
detectable and biological active), the entire proteinase K model
system was performed a second time. The results from the gel
electrophoresis (Figure 5B), ELISAs (Table 5), and bioassays
(Figure 3F) supported the previous ﬁndings.
Proteinase K treatments from the ﬁrst run (Figure 5A) were
silver-stained in an attempt to visualize fragments that might not
have been captured by Coomassie staining. The silver staining
procedure did detect additional bands in the treatments;
however, all of these bands appeared to correspond to additional
bands visualized in the proteinase K control (Figure 5C).
Gel electrophoresis on themass digest (not shown) indicated a
similar degradationpattern as previously observed (Figure 5Aand
B). Gel electrophoresis with the tris-tricine gel adequately
resolved the low–molecular weight fragments (Figure 5D).
Althoughmany of the fragments in the treatment corresponded to
bands in the proteinaseK enzyme control, 2 bands in the treatment
between 3.5 kDa and 6.5 kDa did not appear elsewhere; thus, the
proteinaseKdigestion appears to produce at least 2 fragments that
have low molecular weights.
A G-50 separatory column was used to fractionate the
treatment protein and the proteinase K control and Cry1Ab
protein control. Fraction analysis by Nano-Drop spectropho-
tometry yielded 6 fractions of interest in the treatment. High
concentrations of protein were observed in fractions 4 to 7, 12
and 13 in the treatment (Figure 6). The Cry1Ab control peaked
across fractions 5 and 6, whereas no discernable peaks were
observed in the proteinase K control. For the treatment and the 2
control samples, ELISAs were performed individually on
fractions 4 to 7, 12 and 13. The ELISA results indicate that
Cry1Ab was present in treatment fractions 4 to 7 and in Cry1Ab
control fractions 5 to 7; no protein was detected in any of the
proteinase K control fractions (Table 3).
DISCUSSION
The gel electrophoresis, ELISA, and bioassay results in 4 of
the 5 model systems tested corroborated each other. For the
chymotrypsin model system, at 1 h, only 2 fragments were
observed in the gel, and most of the parent protein remained
intact (Figure 1A). The ELISA results also indicate that similar
amounts of parent protein were present in the treatments and the
control. Bioassays suggest that more European corn borer larval
survival occurred in the 1-h treatments than the Cry1Ab control,
though the cause of this is unknown. At 24 h, the gel
electrophoresis and ELISA results indicate that signiﬁcant
losses of the parent protein occurred. The bioassay results
showed signiﬁcant increases in larval survival; however,
average larval weights were still suppressed. Thus, at 24 h,
sufﬁcient amounts of fully intact Cry1Ab remained to affect
larval growth, but the quantities present were below the
threshold needed for mortality to occur. Even though there was
signiﬁcant variation in the amount of Cry1Ab remaining in the 3
chymotrypsin replicates, this did not affect the overall results as
the present study was focused on whether Cry1Ab fragments
generated by the chymotrypsin model system were
detecTable Since the biological activity and ELISA detectabil-
ity of the protein decrease as the protein becomes fragmented,
the conclusion can be drawn that Cry1Ab fragments generated
by the chymotrypsin model system are not detectable by ELISA
and do not retain any bioactivity.
For the long-term degradation in buffer model system,
multiple fragments of Cry1Ab were generated but substantial
quantities of the fully intact protein remained (Figure 1C). The
ELISA results indicate that approximately half of the protein is
no longer present (Table 4). Increased larval survival in the
treatments suggests that substantial degradation of the protein
occurred, but the low average weight of the insects in the
treatments indicates that enough protein remains intact to
cause sublethal effects (Figure 3A). Based on these results, the
conclusion can be drawn that the fragments generated by
the long-term degradation in buffer model system are not
detectable by ELISAs and do not retain lethal bioactivity at the
concentration tested.
In the photodegradation model system, numerous fragments
were produced following 2.5-min and 5-min exposure to UV
light (Figure 1D). Molecules larger than the 67-kDa parent
protein were also visible in all lanes. These larger molecules are
most likely the result of multiple Cry1Ab molecules (or
fragments) crosslinking to each other and forming dimers or
Figure 4. Degradation of Cry1Ab with the acidic buffer model system.
Incubation times: (A) 4 d to 5 d, (B) 6 d to 7 d. Signiﬁcant degradation
occurred over days 4 through 7, with the protein almost completely
degraded by day 7; but the number and quantity of fragments did not
increase over days 4 through 7.
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other complex molecules. Protein–protein crosslinking is
known to occur at 254 nm [10]. The Cry1Ab protein was
detected in only 1 of 6 treatments by ELISA, despite fully intact
protein being still present in all lanes (Table 4). Detrimental
effects of the fragments were not observed in the bioassays
(though the 5-min treatments seemed to promote insect growth)
(Figure 3B). This suggests that the structure of these fully intact
proteins may have been altered by the UV light to prevent
Table 5. Enzyme-linked immunosorbent assay results from the acidic buffer and proteinase K model systemsa
Absorbance Concentration (ng/mL) Adjusted concentration (ng/mL) % Cry1Ab remainingb
Cry1Ab control 0.713 5.42 121 909
Acidic buffer control 0.007 2.01 0
Acidic buffer day 4c
Room temperature 0.003 2.05 0 0
Replicate 1 0.002 2.06 0 0
Replicate 2 0.010 1.98 0 0
Acidic buffer day 5
Room temperature 0.011 1.97 0 0
Replicate 1 0.009 1.99 0 0
Replicate 2 0.004 2.04 0 0
Acidic buffer day 6
Room temperature 0.175 0.24 0 0
Replicate 1 0.011 1.97 0 0
Replicate 2 0.007 2.00 0 0
Acidic buffer day 7
Room temperature 0.006 2.01 0 0
Replicate 1 0.012 1.95 0 0
Replicate 2 0.013 1.94 0 0
Proteinase K first model system rund
Cry1Ab control 0.726 5.15 102 930
Proteinase K control 0.006 2.73 0
Replicate 1 0.719 5.07 101 471 98.58
Replicate 2 0.690 4.75 95 077 92.37
Replicate 3 0.546 3.17 63 469 62.55
Proteinase K second model system run
Cry1Ab control 0.713 5.62 112 406
Proteinase K control –0.021 2.93 0
Replicate 1 0.695 5.41 108 262 96.31
Replicate 2 0.606 4.37 87 464 77.81
Replicate 3 0.632 4.67 93 370 83.06
a
“Adjusted concentration” was calculated by multiplying by the dilution factor, 1:22 500 (acidic buffer) or 1:20 000 (proteinase K).
b
“% Cry1Ab remaining” was calculated by dividing the concentration of each of the replicates by the Cry1Ab control concentration.
cAcidic buffer: Results indicate signiﬁcant degradation in all treatments and controls at all time points.
dProteinase K: Results from both model system runs indicate little degradation.
Figure 5. Degradation of Cry1Abwith the proteinase Kmodel system. (A) The proteinase Kmodel system completely degraded Cry1Ab. (B) Themodel system
was repeated entirely, and the results were replicated. (C) Silver staining performed on the treatments from the ﬁrst model system run (A) did not detect
additional fragment bands. (D) Fragments generated by mass digest were analyzed with a tris-tricine gel and silver-stained. Two Cry1ab fragment bands of low
molecular weight were identiﬁed (indicated by arrows).
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antibody binding. Disulﬁde bonds can absorb light between
250 nm and 300 nm, which can lead to photo-dissociation of
cystine into 2 thiyl radicals. These radicals can dimerize
(explaining the larger molecules observed in the gel), or they
may react with oxygen, resulting in an irreversible oxidation of
the disulﬁde bond. This oxidation reaction can compromise the
tertiary structure of the protein and result in decreased antibody
binding (from ELISAs) and decreased toxicity [11]. From these
results, the conclusion can be drawn that the fragments
generated by the photodegradation model system do not retain
bioactivity and are not detectable by ELISA.
The acidic buffer model system produced numerous frag-
ments over the 4-d to 7-d degradation period, including nearly
complete degradation of the protein at 7 d (Figure 4). However,
the quantity of fragments produced never increased, and the
amounts of individual fragments did not accumulate, suggesting
continued degradation of the fragments. Fragments from the
acidic buffer model system were not detectable by ELISA
(Table 5). These fragments did not appear to retain bioactivity as
survival in all treatments did not differ from the water control
(Figure 3C and D). Survival in the room temperature controls
also was not signiﬁcantly different from the water control,
though signiﬁcant amounts of parent protein remained, as
observed in the gel (Figure 4). The acidic conditions in these
controls and treatments possibly caused denaturing of the
protein, resulting in a loss of bioactivity and detectability by
ELISA. Denaturing of proteins is known to occur at low
pH [12]. In some cases, denatured proteins may refold into a
molten, globule-like conformation [12,13]; but the exact
conformational state of the proteins and fragments in the
controls and treatments was not investigated in the present
study. Decreased weight of the insects in the 6-d and 7-d
treatments indicate that a sublethal effect may be occurring
(Figure 3D). The average weight in these treatments was
signiﬁcantly higher than the average weight in the Cry1Ab
control; the average weights in other model systems where
survival was not impacted but sublethal effects existed (such as
the proteinase K model system) were not statistically different
from the Cry1Ab control (Figure 3E and F). This suggests that
the effects observed in the 6-d and 7-d treatments might not be
attributable to Cry1Ab fragments but rather to other factors. The
average weight in the 5-d treatment was statistically higher than
the water control, further supporting the possibility that
variation in the biological systems is responsible for the weight
differences. Based on the results of the acidic buffer model
system, the conclusion can be drawn that the fragments
generated by this model system are not detectable by ELISA
and do not appear to retain any biological activity.
For these 4 model systems, the conclusion can be drawn that
the fragments generated by themodel systems are not detectable
by ELISA since the concentrations of Cry1Ab in the treatment
solutions decreased. If the fragments were detectable by the
ELISA, it would be expected that the concentrations of Cry1Ab,
as determined by the ELISA, would remain unchanged or even
increase, if multiple fragments capable of binding with the
antibodies were formed from the degradation of a single protein.
The proteinase K model system produced different results
because initial tests on the fragments generated by the
proteinase K model system suggested that the fragments were
still detectable by ELISA and retained bioactivity
(Figure 3E and Table 5). The model system digestion was
repeated, and the results of the ﬁrst digestion were replicated
(Figures 3F and 5B and Table 5). These positive ELISA and
bioassay results were unexpected, given the low molecular
weight of these fragments (Figure 5D). A separatory column
was used in an attempt to isolate separate fragments and test
each fragment or a smaller collection of fragments with
ELISAs. This separation resulted in 6 fractions of interest:
fractions 4 to 7, 12, and 13 (Figure 6). The largest peak in the
treatment was centered across fractions 4 to 7, which aligned
with the peak in the Cry1Ab control. This is surprising because
the Sephadex G-50 medium used in the separatory column has a
cutoff of approximately 30 kDa; proteins larger than 30 kDa
should have eluted in the ﬁrst few fractions, whereas proteins
Figure 6. Graph of results of Sephadex G-50 separatory column for total protein concentration versus fraction number. Initial sample volume was 3mL. A
majority of the protein in the treatment appears in fractions 4 through 7, suggesting that a larger fragment and/or fully intact protein is present. Fractions 4 through
7, 12, and 13 in all treatments were analyzed by enzyme-linked immunosorbent assay. Cry1Ab¼Cry1Ab only; Pr. K¼ proteinase K enzyme only;
Treatment¼Cry1Ab degraded with proteinase K.
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smaller than 30 kDa should have eluted in later fractions. This
was true for the Cry1Ab control as the fully intact protein
(67 kDa) elutes early in the column (fractions 5 and 6; Figure 6).
This suggests that high–molecular weight proteins (>30 kDa)
were still present in the treatment; however, no proteins
>30 kDa were observed in the gels (Figure 5).
One possible explanation for the fragments still being
detectable by ELISA is that the proteinase K fragments may still
be immunoreactive with the ELISA antibodies. Lutz et al. [7]
detected Cry1Ab with ELISA in gastrointestinal tract samples
from cattle fed transgenic maize; however, western blotting
indicated that only 17-kDa and 34-kDa fragments were present.
Emmerling et al. [14] detected small amounts of Cry1Ab with
ELISA in hindgut and cast material samples from earthworms.
Western blotting did not detect any fragments, leading the
authors to speculate that the fragments detected by the ELISA
were smaller than 17 kDa. The fragments in the present study
meet these criteria, as they are believed to be between 3.5 kDa
and 6.5 kDa in size. However, this does not explain why the
fragments moved through a separatory column in a manner
similar to larger proteins or why the fragments still exhibited
biological activity. Some fragments of Cry proteins are known
to retain biological activity. Diaz-Mendoza et al. [15] reported
that 43-kDa and 46-kDa fragments of Cry1Ab (69-kDa active
form) generated by a trypsin puriﬁed from the Mediterranean
corn borer, Sesamia nonagrioides, were still toxic to
S. nonagrioides larvae. However, no other known studies
have tested the bioactivity of Cry protein fragments with very
low molecular weights; it seems unlikely that a highly degraded
fragment (17 kDa or less) would retain enough structure to bind
to and insert into an insect’s midgut cells and, ultimately, result
in toxicity.
Another possible explanation is that proteinase K degraded
the protein, but the fragments then reassociated with each other,
possibly through disulﬁde bridges. Proteinase K cleaves at the
carboxylic group of aliphatic and aromatic amino acids with
blocked a-amino groups; disulﬁde bridges may not be affected
by this cleavage [16]. Fragments may be visualized in gel
electrophoresis because the denaturing conditions in SDS-
PAGE break the disulﬁde bonds, causing the fragments to
dissociate from each other. If the fragments do reassociate with
each other, they would have a higher overall molecular weight,
which would cause them to pass though the separatory column
quickly and elute in earlier fractions, similar to fully intact,
large–molecular weight proteins. This also may explain
the positive ELISA and bioassay results; the association of
the fragments may allow the protein to retain enough of its
native conformation to allow for antibody binding (resulting in
positive ELISA detections) and binding to the insect midgut
(resulting in toxicity).
Two studies observed similar processes with Cry4A and
Cry11A. Two Cry4A fragments of 20 kDa and 45 kDa were
formed by in vitro and in vivo processing [17]. Individually, the 2
fragments exhibited no toxicity against Culex pipiens larvae;
however, when the 2 fragments were mixed together, signiﬁcant
toxicity was observed. The authors proposed that the 2 fragments
associated with each other to form an insecticidal complex since
the fragments could not be separated by gel ﬁltration; fragment
associationwas conﬁrmedwith coprecipitation experiments [17].
Similar results were observed with Cry11A, for which a 32-kDa
and a 36-kDa fragment had no toxicity individually but exhibited
signiﬁcant toxicity when expressed together [18]. The 2
fragments also eluted together in size-exclusion chromatography,
and coprecipitation experiments determined that they were
associated with each other [18]. A similar inability to resolve the
fragments with gel ﬁltration was observed in the present study,
supporting the theory that the fragments were associated with
each other.More research is needed to conﬁrm this association of
fragments.
CONCLUSIONS
Five model systems were used to generate fragments of
Cry1Ab. In 4 of these model systems—chymotrypsin model
system, acidic buffer model system, photodegradation model
system, and long-term degradation in buffer model system—the
fragments generated were not detectable by ELISA and did not
retain bioactivity. In the proteinase K model system, the
fragments generated were detectable by ELISA and retained
bioactivity. The reason for this is unknown; more research is
needed to understand this phenomenon. Nevertheless, based on
the present results, researchers do not appear to be over-
estimating the amount of Cry proteins in the environment as
fragments that are detectable by the ELISA kit used in the
present study also retain bioactivity, and those fragments not
detectable by this ELISA have no biological activity. However,
only a few mechanisms of Cry protein degradation were
investigated. Additionally, an ELISA from only 1 manufacturer
was used. Other manufacturers may use different host
organisms to produce antibodies for their ELISA kits, and
these antibodies may bind to different epitopes on the
fragmented protein, potentially generating different results.
Thus, more research is needed with other ELISA kits and
additional model systems, especially microbe-based model
systems, to obtain a better understanding of the fate of Cry
proteins in the environment.
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